Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Alkhatib

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|February 25, 2023
Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and TreatmentAhmad R Alsayed, Anas Abed, Heba A Khader, et al.
Microorganisms|February 25, 2022
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario?Mohammad Alkhatib, Maria Concetta Bellocchi, Greta Marchegiani, et al.
Methods (San Diego, Calif.)|May 17, 2021
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartmentLorenzo Piermatteo, Rossana Scutari, Riccardo Chirichiello, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2026
Investigating substituted phenylacetamide ligands in the D<sub>4</sub>R extended binding pocketTian Li, Mohammad Alkhatib, Peter A Ramdhan, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 2, 2020
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronavirusesAnna Artese, Valentina Svicher, Giosuè Costa, et al.
Journal of Chemical Information and Modeling|May 25, 2023
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an <i>In Silico</i> Drug Repurposing ApproachFrancesca Alessandra Ambrosio, Giosuè Costa, Isabella Romeo, et al.
Microbiology Spectrum|November 17, 2021
SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021Mohammad Alkhatib, Valentina Svicher, Romina Salpini, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing ApproachIsabella Romeo, Francesca Alessandra Ambrosio, Giosuè Costa, et al.
Microbiology Spectrum|March 30, 2022
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational ProfileMohammad Alkhatib, Romina Salpini, Luca Carioti, et al.
The Journal of Antimicrobial Chemotherapy|November 30, 2020
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune controlRomina Salpini, Mohammad Alkhatib, Giosuè Costa, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|February 25, 2023
Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and TreatmentAhmad R Alsayed, Anas Abed, Heba A Khader, et al.
Microorganisms|February 25, 2022
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario?Mohammad Alkhatib, Maria Concetta Bellocchi, Greta Marchegiani, et al.
Methods (San Diego, Calif.)|May 17, 2021
Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartmentLorenzo Piermatteo, Rossana Scutari, Riccardo Chirichiello, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2026
Investigating substituted phenylacetamide ligands in the D<sub>4</sub>R extended binding pocketTian Li, Mohammad Alkhatib, Peter A Ramdhan, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 2, 2020
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronavirusesAnna Artese, Valentina Svicher, Giosuè Costa, et al.
Journal of Chemical Information and Modeling|May 25, 2023
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an <i>In Silico</i> Drug Repurposing ApproachFrancesca Alessandra Ambrosio, Giosuè Costa, Isabella Romeo, et al.
Microbiology Spectrum|November 17, 2021
SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021Mohammad Alkhatib, Valentina Svicher, Romina Salpini, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing ApproachIsabella Romeo, Francesca Alessandra Ambrosio, Giosuè Costa, et al.
Microbiology Spectrum|March 30, 2022
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational ProfileMohammad Alkhatib, Romina Salpini, Luca Carioti, et al.
The Journal of Antimicrobial Chemotherapy|November 30, 2020
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune controlRomina Salpini, Mohammad Alkhatib, Giosuè Costa, et al.
Pageof 5